NEW YORK (Reuters Health)—Mindfulness-based stress reduction (MBSR) is more effective than treatment as usual for improving function and other outcomes in patients with fibromyalgia, according to a new randomized trial. MBSR is an extension of cognitive-behavioral therapy (CBT) intended to help patients change the way they experience symptoms, Dr. Albert Feliu-Soler of the Institut de…
Search results for: stress
An Interdisciplinary & Holistic Approach to Alleviating Pediatric Pain
Interdisciplinary collaboration is proving valuable to address bio-psycho-social pain management in pediatric patients at Children’s Hospital Los Angeles…
Expert Says Vaccines Are Largely Safe for Rheumatology Patients
CHICAGO—Rheumatologists often come to Brian Schwartz, MD, associate professor of medicine and vice chief for clinical affairs in the Division of Infectious Diseases, University of California, San Francisco, with a concern: A patient on immunosuppression has a family member who needs a live vaccine, but the patient may be vulnerable to the vaccine’s effects. Should…
Basic Science Sessions: Diverse Topics, Wide Appeal
Machine learning, immunology, the metabolism—are just a few of the topics addressed during…
What Physical & Occupational Therapists Wish Rheumatologists Knew
Kim Steinbarger, PT, MHS, knows how physical and occupational therapy can make a difference for patients with rheumatic diseases. Ms. Steinbarger was just two years into her career as a physical therapist (PT) when she was diagnosed with rheumatoid arthritis (RA) in 1991. “I’ve seen how regular exercise serves as an important tool in managing…
Vaccines & Rheumatology Patients
Vaccines are often safe for rheumatology patients, but precautions may be needed, said Brian Schwartz, MD, at the 2019 ACR State-of-the-Art Clinical Symposium…
Recent Trials Investigated Targeted Therapies for Systemic Sclerosis
SNOWMASS VILLAGE, COLO.—Data from three recent trials in systemic sclerosis (scleroderma) provide information on a number of important issues related to screening and treatment. First presented at the 2018 ACR/ARHP Annual Meeting, the phase 2/3 trials assessed the safety and efficacy of targeted agents to treat patients with systemic sclerosis.1-3 In a follow-up presentation at…
Houston Rheumatologist Explores Rarities in Both Medicine & Nature
Farokh Jamalyaria, MD, a rheumatologist in Houston, never set out to become a birder. He remembers his first foray into birding as being completely unintentional. At 8 years old, while living in Ruston, La., he showed his mother an image of an ivory-billed woodpecker—an extinct species last spotted in the 1940s about 100 miles from…
Psoriatic Arthritis: A Look Back at Moll & Wright’s Landmark 1973 Paper
Psoriatic arthritis came to be viewed as a distinct disease entity with specific clinical features, genetics and pathophysiology only gradually. One important historic development in this transition was a 1973 paper written by a pair of researchers out of Leeds, England: John M. Moll, BSc, DM, and Verna Wright, MD, FRCP.1 Here we discuss the…
Ultrasound Image Review: A 30-Year-Old Woman with Left Foot Pain
Presentation A 30-year-old woman presented to her rheumatologist for left foot pain of three weeks’ duration. She was followed for systemic lupus erythematosus manifesting in arthritis and hemolytic anemia, as well as anti-nuclear antibody and Smith antibody positivity, and was treated with hydroxychloroquine and prednisone in the 2.5–10 mg per day range. She was symptom…
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 91
- Next Page »